rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2008-11-13
|
pubmed:abstractText |
Angiostatin, a circulating angiogenic inhibitor, is an internal fragment of plasminogen and consists of several isoforms, K1-3 included. We previously showed that K1-3 was the most potent angiostatin to induce E-selectin mRNA expression. The purpose of this study was to identify the mechanism responsible for K1-3-induced E-selectin expression and investigate the role of E-selectin in the anti-angiogenic action of K1-3.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1538-7836
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1953-61
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18761727-Angiostatins,
pubmed-meshheading:18761727-Binding Sites,
pubmed-meshheading:18761727-Caveolin 1,
pubmed-meshheading:18761727-Cell Line,
pubmed-meshheading:18761727-Cell Line, Tumor,
pubmed-meshheading:18761727-E-Selectin,
pubmed-meshheading:18761727-Humans,
pubmed-meshheading:18761727-JNK Mitogen-Activated Protein Kinases,
pubmed-meshheading:18761727-Kinetics,
pubmed-meshheading:18761727-Membrane Microdomains,
pubmed-meshheading:18761727-Promoter Regions, Genetic,
pubmed-meshheading:18761727-Protein Binding,
pubmed-meshheading:18761727-Protein Isoforms,
pubmed-meshheading:18761727-Proto-Oncogene Protein c-ets-1,
pubmed-meshheading:18761727-RNA, Messenger,
pubmed-meshheading:18761727-Transcription Factor AP-1,
pubmed-meshheading:18761727-Transcriptional Activation
|
pubmed:year |
2008
|
pubmed:articleTitle |
Angiostatin K1-3 induces E-selectin via AP1 and Ets1: a mediator for anti-angiogenic action of K1-3.
|
pubmed:affiliation |
Institute of Basic Medical Sciences, College of Mdicine, National Cheng Kung University, Tainan, Taiwa, ROC.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|